drugset / Trial / NCT06238349
Hyperbilirubinemia in Full-term Neonates
Phase 4
Unknown
200 enrolled
Zhuhai Center for Maternal and Child Health Care
Children's Hospital of Chongqing Medical University · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
To evaluate the efficacy and safety of sunbathing and Bifidobacterium alone or in combination for full-term neonates with hyperbilirubinemia. The investigators hypothesize that the combination therapy of sunbathing plus Bifidobacterium is safe and effective for prevention and management of hyperbilirubinemia in full-term neonates. The investigators therefore design this prospective, randomized, controlled study to assess the preventive effects of sunbathing combined with Bifidobacterium supplementation on hyperbilirubinemia in full-term neonates. These observations may provide scientific evidence for the use of sunbathing and Bifidobacterium supplementation in the management of hyperbilirubinemia in full-term neonates.
Timeline
- Start
- 2024-01-23
- Primary completion
- 2024-06-21
- Completion
- 2024-06-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bifidobacterium triple viable powder | Other / unclassified | 0.5 g | Oral |